Telemedicine in the treatment of patients with inflammatory bowel disease
Autores de IIS La Fe
Grupos
Abstract
Inflammatory bowel disease (IBD) is a chronic and relapsing disorder with significant medical, social and financial impacts. IBD patients require continuous follow-up, and healthcare resource use in this context increases over time. In the last decade, telemedicine has influenced the treatment of chronic diseases like IBD via the application of information and communication technologies to provide healthcare services remotely. Telemedicine and its various applications (telemanagement, teteconsulting and tele-education) enable closer follow-up and provide education resources that promote patient empowerment, encouraging treatment optimisation over the entire course of the disease. We describe the impact of using telemedicine on IBD health outcomes and discuss the limitations of implementing these systems in the real-life management of IBD patients. (C) 2017 Elsevier Espana, S.L.U., AEEH y AEG. All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 0210-5705, 0210-5705
- Tipo:
- Review
- Páginas:
- 641-647
- PubMed:
- 28797518
- Factor de Impacto:
- 0,218 SCImago ℠
- Cuartil:
- Q3 SCImago ℠
Gastroenterologia y Hepatologia ELSEVIER ESPANA SLU
Citas Recibidas en Web of Science: 11
Documentos
- No hay documentos
Filiaciones
Keywords
- Inflammatory bowel disease; Information and communication technology; e-health; Telemedicine
Portal de investigación